Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.95 - $4.84 $71,890 - $88,088
-18,200 Reduced 32.56%
37,700 $152,000
Q1 2024

May 15, 2024

BUY
$4.7 - $7.58 $50,290 - $81,106
10,700 Added 23.67%
55,900 $267,000
Q4 2023

Feb 14, 2024

BUY
$6.89 - $11.04 $87,503 - $140,208
12,700 Added 39.08%
45,200 $341,000
Q3 2023

Nov 14, 2023

BUY
$10.21 - $14.65 $222,578 - $319,370
21,800 Added 203.74%
32,500 $333,000
Q2 2023

Aug 14, 2023

SELL
$13.68 - $16.56 $82,080 - $99,359
-6,000 Reduced 35.93%
10,700 $147,000
Q1 2023

May 15, 2023

SELL
$15.9 - $22.22 $283,020 - $395,516
-17,800 Reduced 51.59%
16,700 $271,000
Q4 2022

Feb 14, 2023

SELL
$17.16 - $22.14 $466,752 - $602,208
-27,200 Reduced 44.08%
34,500 $610,000
Q3 2022

Nov 14, 2022

BUY
$19.35 - $23.52 $63,855 - $77,616
3,300 Added 5.65%
61,700 $1.2 Million

Others Institutions Holding PETS

About PETMED EXPRESS INC


  • Ticker PETS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 21,013,800
  • Market Cap $81.7M
  • Description
  • PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...
More about PETS
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.